Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-05-20 @ 4:52 AM
Study NCT ID:
NCT00758693
Status:
WITHDRAWN
Last Update Posted:
2012-01-11
First Post:
2008-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
Sponsor:
University of Kentucky
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
08-LEUK-07-MCC/CI
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |